Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MaxCyte Inc.

    NASDAQ: MXCT · Real-Time Price · USD
    2.15
    -0.24 (-10.04%)
    At close: Jun 05, 2025, 3:59 PM
    2.19
    2.10%
    After-hours: Jun 05, 2025, 06:50 PM EDT

    MaxCyte Statistics

    Share Statistics

    MaxCyte has 106.32M shares outstanding. The number of shares has increased by 1.42% in one year.

    Shares Outstanding

    n/a
    		 106.32M

    Shares Change (YoY)

    n/a
    		 1.42%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 69.07%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 3,026

    FTD / Avg. Volume

    n/a
    		 0.34%

    Short Selling Information

    The latest short interest is 3.83M, so 3.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.83M

    Short % of Shares Out

    n/a
    		 3.6%

    Short % of Float

    n/a
    		 3.62%

    Short Ratio (days to cover)

    n/a
    		 3.42

    Valuation Ratios

    The PE ratio is -10.62 and the forward PE ratio is -7. MaxCyte's PEG ratio is -1.97.

    PE Ratio

    n/a
    		 -10.62

    Forward PE

    n/a
    		 -7

    PS Ratio

    n/a
    		 11.29

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 2.11

    P/FCF Ratio

    n/a
    		 -14.91

    PEG Ratio

    n/a
    		 -1.97
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for MaxCyte.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.88, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 10.88

    Quick Ratio

    n/a
    		 10.32

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.39

    Debt / FCF

    n/a
    		 -0.62

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $338,833.33

    Profits Per Employee

    n/a
    		 $-360,131.58

    Employee Count

    n/a
    		 114

    Asset Turnover

    n/a
    		 0.16

    Inventory Turnover

    n/a
    		 0.8

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -55.49% in the last 52 weeks. The beta is 1.04, so MaxCyte's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.04

    52-Week Price Change

    n/a
    		 -55.49%

    50-Day Moving Average

    n/a
    		 2.52

    200-Day Moving Average

    n/a
    		 3.58

    Relative Strength Index (RSI)

    n/a
    		 39.57

    Average Volume (20 Days)

    n/a
    		 894,090

    Income Statement

    In the last 12 months, MaxCyte had revenue of 38.63M and earned -41.05M in profits. Earnings per share was -0.39.

    Revenue

    n/a
    		 38.63M

    Gross Profit

    n/a
    		 31.53M

    Operating Income

    n/a
    		 -51.2M

    Net Income

    n/a
    		 -41.05M

    EBITDA

    n/a
    		 -46.41M

    EBIT

    n/a
    		 -51.2M

    Earnings Per Share (EPS)

    n/a
    		 -0.39
    Full Income Statement

    Balance Sheet

    The company has 27.88M in cash and 18.03M in debt, giving a net cash position of 9.85M.

    Cash & Cash Equivalents

    n/a
    		 27.88M

    Total Debt

    n/a
    		 18.03M

    Net Cash

    n/a
    		 9.85M

    Retained Earnings

    n/a
    		 -216.85M

    Total Assets

    n/a
    		 229.96M

    Working Capital

    n/a
    		 143.01M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -27.61M and capital expenditures -1.65M, giving a free cash flow of -29.26M.

    Operating Cash Flow

    n/a
    		 -27.61M

    Capital Expenditures

    n/a
    		 -1.65M

    Free Cash Flow

    n/a
    		 -29.26M

    FCF Per Share

    n/a
    		 -0.28
    Full Cash Flow Statement

    Margins

    Gross margin is 81.62%, with operating and profit margins of -132.54% and -106.29%.

    Gross Margin

    n/a
    		 81.62%

    Operating Margin

    n/a
    		 -132.54%

    Pretax Margin

    n/a
    		 -106.29%

    Profit Margin

    n/a
    		 -106.29%

    EBITDA Margin

    n/a
    		 -120.14%

    EBIT Margin

    n/a
    		 -132.54%

    FCF Margin

    n/a
    		 -75.75%

    Dividends & Yields

    MXCT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MXCT is $9, which is 318.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 318.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.61

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist